Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma
Clinical trial NCT04933942 · WITHDRAWN
Trial details
- NCT number
- NCT04933942
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2022-12-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.